Drugs News and Research

RSS

Using artificial intelligence methods to predict the prevalence of ALS

Amyotrophic lateral sclerosis (ALS)—a severe disease of the motor nervous system—is hereditary, but a large part of this heritability has previously been unexplained.

28 Feb 2023

Weight loss in obese subjects could reverse type 2 diabetes progression

A new paper explains a model of diabetes that centers on the role of obesity in glucose dysregulation.

28 Feb 2023

Study reveals new mechanism in the arms race between bacteria and viruses

UT Southwestern biochemist Zhijian "James" Chen, Ph.D., famously identified the cGAS enzyme pathway that alerts the human immune system to disease-causing invaders like viruses.

28 Feb 2023

Inexpensive combo-chemotherapy found to be better tolerated than BCG for common bladder cancer

An on-going, worldwide shortage of bacillus Calmette-Guérin (BCG) means that many patients with a common and serious type of bladder cancer have limited access to this effective standard of care treatment.

28 Feb 2023

Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment

Investors include Cambridge Angels, Meltwind, o2h Ventures, SyndicateRoom, and Angel investors, with support from KPMG Acceleris.

From Five Alarm Bio 28 Feb 2023

CN Bio extends microphysiological system portfolio with PhysioMimix Single-Organ Higher Throughput System

CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced the commercial launch of the PhysioMimix™ Single-organ Higher Throughput (HT) System.

From CN Bio 28 Feb 2023

NYC makes clear its intent to lead on abortion access

New York City has long been a haven for people who want an abortion, and new city programs and policies aim to make sure it remains one since the Supreme Court reversed Roe v. Wade and tossed abortion regulation back to the states.

28 Feb 2023

Rare Diseases Action Plan for England focuses on providing better care and reducing health inequalities

A new Rare Diseases Action Plan for England will be published today (Tuesday 28 February) that will ensure those living with these conditions receive better care and treatment, fairer access to testing and have continued support.

28 Feb 2023

Tiny worm enables scientists to explore the theory that Parkinson's disease starts in the gut

A tiny worm called the C. elegans is enabling scientists to explore the emerging theory that Parkinson's disease starts in the gut.

28 Feb 2023

Growing use of immunotherapy linked to increase in Medicare spending for outpatient terminal cancer care

A new study finds that recent increases in Medicare spending on outpatient cancer care at the end of patients' lives were driven almost entirely by a type of treatment given to fewer than 1 in 5 patients.

27 Feb 2023

Large cell therapy trial in patients with chronic heart failure shows promising results

Physician-scientists at The Texas Heart Institute announced today the results of the largest cell therapy trial to date in patients with chronic heart failure due to low ejection fraction.

27 Feb 2023

Combining a chemical blocker of immune cell exit with immunotherapy stops skin cancer growth

The number of specialized immune cells available for fighting skin cancer doubled when a new treatment blocked their escape from melanoma tumors, experiments in mice and human cells show.

27 Feb 2023

After capping the price of insulin, Colorado sets its sights on EpiPens

Almost four years after becoming the first state to cap insulin prices, Colorado may limit what consumers pay for epinephrine autoinjectors, also known as EpiPens, which treat serious allergic reactions.

27 Feb 2023

High-dose ivermectin does not reduce COVID-19 symptom duration among mild-to-moderate outpatients

Researchers evaluate the efficacy of ivermectin in a maximum dosage of 600 μg/kg/day over six days in treating early mild-to-moderate COVID-19.

27 Feb 2023

Comprehensive plan for phasing out the use of animals in experimentation

PETA scientists have just released a new edition of the groundbreaking Research Modernization Deal (RMD), the world's first comprehensive plan for phasing out the use of animals in experimentation. The update is packed with new, cutting-edge information and reflects the latest scientific developments and regulatory changes since the RMD was first introduced in 2018.

27 Feb 2023

Cannabis users have higher complexity of co-existing conditions

As legislation in multiple states eases former restrictions around medical and recreational cannabis in the United States, an increasing proportion of the population reports use of the drug. Between 2016 and 2018, more than 22 percent of Massachusetts residents reported any prior cannabis use for medical or recreational reasons. However, little is known about cannabis use in patients who undergo surgery or interventional procedures, where cannabis use has important additional clinical implications.

27 Feb 2023

Drugs News and Research

Using artificial intelligence methods to predict the prevalence of ALS

Weight loss in obese subjects could reverse type 2 diabetes progression

Study reveals new mechanism in the arms race between bacteria and viruses

Inexpensive combo-chemotherapy found to be better tolerated than BCG for common bladder cancer

Five Alarm Bio, Focused on Minimising the Effects of Aging in Humans, Raises Seed Investment

CN Bio extends microphysiological system portfolio with PhysioMimix Single-Organ Higher Throughput System

NYC makes clear its intent to lead on abortion access

Rare Diseases Action Plan for England focuses on providing better care and reducing health inequalities

Tiny worm enables scientists to explore the theory that Parkinson's disease starts in the gut

Growing use of immunotherapy linked to increase in Medicare spending for outpatient terminal cancer care

Large cell therapy trial in patients with chronic heart failure shows promising results

Combining a chemical blocker of immune cell exit with immunotherapy stops skin cancer growth

After capping the price of insulin, Colorado sets its sights on EpiPens

High-dose ivermectin does not reduce COVID-19 symptom duration among mild-to-moderate outpatients

Comprehensive plan for phasing out the use of animals in experimentation

Cannabis users have higher complexity of co-existing conditions

Determining the role of the epigenetic enzyme, HDAC5, in an animal model

Novel microfluidic model mimics a rare genetic disorder

Study establishes new pre-clinical model to develop clinically relevant treatments for heart attacks

Research identifies proteins that may contribute to onset of common metabolic diseases

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News